Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

Agonists of the nuclear receptor PPARγ are therapeutically used to combat hyperglycaemia associated with the metabolic syndrome and type 2 diabetes. In spite of being effective in normalization of blood glucose levels, the currently used PPARγ agonists from the thiazolidinedione type have serious si...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wang, Limei, Waltenberger, Birgit, Pferschy-Wenzig, Eva-Maria, Blunder, Martina, Liu, Xin, Malainer, Clemens, Blazevic, Tina, Schwaiger, Stefan, Rollinger, Judith M., Heiss, Elke H., Schuster, Daniela, Kopp, Brigitte, Bauer, Rudolf, Stuppner, Hermann, Dirsch, Verena M., Atanasov, Atanas G.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science 2014
Matèries:
Part of the Special Issue: Metabolism 2014 – Alterations of metabolic pathways as therapeutic targets
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4212005/
https://ncbi.nlm.nih.gov/pubmed/25083916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2014.07.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars